Rapeseed Artemis

Genetic Immunity Against Pathogens

The winter rapeseed hybrid 'Artemis' from Limagrain is a breeding product focused on addressing the primary challenge of intensive farming: phytosanitary pressure. The key feature of this hybrid lies in its multi-level protection against a complex of diseases that annually account for up to 30% of yield losses. Breeders at Limagrain Europe focus on genetics resistant to verticillium and phoma — fungal pathogens capable of destroying the plant's vascular system during the pod-filling stage.

Technical Parameters and Yield Potential

As a simple linear hybrid, 'Artemis' demonstrates excellent crop uniformity. This is critical for mechanized harvesting: even maturation eliminates grain loss during combining. Key technical specifications of the hybrid include:

• Yield potential: 40–50 c/ha under optimal agronomic conditions.
• Biochemical profile: Glucosinolate content is maintained within a narrow range of 14–15 mMol, meeting quality standards for processing.
• Phytosanitary barrier: Selection is targeted at mitigating the risks of cylindrosporiosis and viral infections, including yellowing viruses and leaf roll viruses.

Choosing 'Artemis' is a commitment to reducing fungicide application costs. Resistance to aphid-transmitted viral diseases makes the hybrid less dependent on autumn insecticide treatments. Limagrain’s French breeding program ensures rapid vegetative biomass regeneration after winter dormancy, providing a competitive edge against weeds at the start of spring vegetation.